Browse by ▼

Rite Aid Corp

  • More Upside Still for Rite Aid?

    By Nick Chiu - May 22, 2013 | Tickers: CVS, RAD, WAG

    Rite Aid (NYSE: RAD) is one of the nation’s largest drugstore chains, operating drugstores in 31 states across the U.S. and in the District of Columbia. Rite Aid continues to rally despite the declining same store sales for April. Rite Aid’s share price had more than doubled since the beginning of the year, outperforming Walgreen (NYSE: WAG) and CVS Caremark (NYSE: CVS). Walgreen had advanced 34.78 more »

  • This Company Is Making a Killing on the Patent Cliff

    By Mohammed Shaaban - May 22, 2013 | Tickers: CVS, RAD, WAG | Editor's Choice

    If you have been following the pharmaceutical industry lately, then you're probably no stranger to the "Patent Cliff" phenomenon that the industry is facing. The giant pharmaceutical companies are struggling to get new medications approved to replace the onslaught of blockbuster drugs that were approved in the 1990s, and are currently going off patent year after year.

    This following is a chart depicting the number of new medications approved more »

  • Are These Top Performers A Sell?

    By Brian Nichols - May 21, 2013 | Tickers: ACAD, RAD

    Late last year I began using Motley Fool’s My CAPS as a way for readers to track my new investments and those that fit under the guidelines in my book Taking Charge With Value Investing (McGraw-Hill, 2013). The concept of CAPS is to make selections based on a time allowed and then you earn points for every percent that your selections outperform its index. The score is then totaled more »

  • Will Rite Aid’s Rally Continue?

    By Lior Cohen - May 20, 2013 | Tickers: CVS, RAD, WAG

    The health store sector isn’t showing signs of recovery; revenues of leading drugstore chains remained stable as in the case of Walgreen (NYSE: WAG) or slightly declined as in the case of Rite Aid (NYSE: RAD). And yet these companies’ stocks continue to trade up. The company that led the charge in the stock market in recent months was Rite Aid as its stock spiked by more than 91 more »

  • The Generic Shift Leaves Pharmacy Investors Well Positioned

    By Brian Nichols - May 6, 2013 | Tickers: CVS, RAD, WAG

    All three of the major pharmacy companies, Rite Aid (NYSE: RAD), CVS Caremark (NYSE: CVS), and Walgreen (NYSE: WAG), operate with similar business models, having both retail and pharmacy segments. Yet for all of these three companies, the pharmacy business is the most watched and produces the greatest difference in sales and margins. With that said, anyone following the space must be glad with what they are seeing develop.

    A more »

  • Will This "Perfect" Drug Retail Stock Continue to Dominate?

    By Nauman Aly - April 29, 2013 | Tickers: CVS, RAD, WAG

    In many cities across the U.S., you would be hard pressed not to find a CVS Caremark (NYSE: CVS) location on just about every street corner. Some analysts have stated that as this company continues to grow, it has shown signs of being "the perfect stock" - inclusive of both excellent returns and sizable gains. But how long will CVS continue on its steady uptrend?

    Finding a cure for growing more »

  • Why I'm Not Buying This New Look Company

    By Brian Nichols - April 29, 2013 | Tickers: RAD, SVU

    Prior to Thursday’s 2% loss, shares of SUPERVALU (NYSE: SVU) traded higher by more than 8% on Wednesday after reporting earnings. Strangely enough, the stock actually traded lower by as much as 6.5% before reversing significantly higher. These large gains were not the result of fundamental greatness in the quarter, but rather speculation, and an idea of future greatness.

    SUPERVALU & Its “Plan”

    For FQ4, SUPERVALU saw revenue of more »

  • Is Walgreen a Good Stock to Buy?

    By Meena Krishnamsetty - April 20, 2013 | Tickers: CVS, ESRX, RAD, WMT, WAG

    In the last year, the stock price of Walgreen Company (NYSE: WAG) has risen 48% following the settlement of its dispute with Express Scripts (NASDAQ: ESRX). The second quarter of the $46 billion market cap retail pharmacy’s fiscal year ended in February, with Walgreen reporting flat revenue compared to the same period in the previous fiscal year. With lower cost of goods sold offsetting increases in SGA expenses, however more »

  • A $2.30 Stock that is Worth Sprint’s $7.00 Buy Offer

    By Brian Nichols - April 17, 2013 | Tickers: RAD, S

    The acquisition spree for Sprint Nextel (NYSE: S) continues to heat up, as Dish Networks makes a bid to acquire. The latest offer would be to purchase the company for $7 per share, a premium of more than 200% from its January 2012 low. While Sprint continues to catch the market’s eye late, Rite Aid (NYSE: RAD) is another acquisition target that is worth the same $7 per share more »

  • A $2.30 Stock that is Worth Sprint’s $7.00 Buy Offer

    By Brian Nichols - April 17, 2013 | Tickers: RAD, S

    The acquisition spree for Sprint Nextel (NYSE: S) continues to heat up, as Dish Networks makes a bid to acquire. The latest offer would be to purchase the company for $7 per share, a premium of more than 200% from its January 2012 low. While Sprint continues to catch the market’s eye late, Rite Aid (NYSE: RAD) is another acquisition target that is worth the same $7 per share more »

  • Is Walgreen Company a Good Stock to Buy?

    By Meena Krishnamsetty - April 16, 2013 | Tickers: CVS, ESRX, RAD, WMT, WAG

    In the last year, the stock price of Walgreen Company (NYSE: WAG) has risen 48% following the settlement of its dispute with Express Scripts (NASDAQ: ESRX). The second quarter of the $46 billion market cap retail pharmacy’s fiscal year ended in February, with Walgreen reporting flat revenue compared to the same period in the previous fiscal year. With lower cost of goods sold offsetting increases in SGA expenses, however more »

  • Market Moving Upgrades Worth Noting on Friday

    By Brian Nichols - April 15, 2013 | Tickers: HD, IP, RAD

    Stocks can be pushed higher or lower as analysts provide their outlooks. These calls are not enough to base an investment on, but should be considered as part of your research. Therefore, I am assessing a few of Friday’s top calls, and determining if each was a good call.

    Rite Aid (NYSE: RAD)

    After a huge post-earnings pop on Thursday, shares of Rite Aid traded higher by another 5 more »

  • A $2.30 Stock that is Worth Sprint’s $7.00 Buy Offer

    By Brian Nichols - April 15, 2013 | Tickers: RAD, S

    The acquisition spree for Sprint Nextel (NYSE: S) continues to heat up, as Dish Networks makes a bid to acquire. The latest offer would be to purchase the company for $7 per share, a premium of more than 200% from its January 2012 low. While Sprint continues to catch the market’s eye late, Rite Aid (NYSE: RAD) is another acquisition target that is worth the same $7 per share more »

  • Do March Sales Predict Annual Performance?

    By Austin Higgins - April 15, 2013 | Tickers: CVS, RAD, WAG

    Retail drugstores recently reported March sales. Of the three largest drug stores, two saw sales growth while one experienced a decline. While this is only one month's worth of performance, what does this signal for investors in big retail drugstore stocks this year?

    Walgreen 

    Walgreen (NYSE: WAG) had sales of approximately $6.2 billion, which was a 2.3% increase from the same time last year. The report has more »

  • Five Reasons to Buy This Stock on the Rise

    By AnnaLisa Kraft - April 14, 2013 | Tickers: CVS, RAD, WAG

    Imagine munching on delicacies like sushi or frozen yogurt or getting a manicure while you wait for your prescription. Maybe you're taken ill with a miserable sinus infection or a sprain. You feel like h*ll but who wants the hassle and expense of going to the emergency room after your physician's office closes. You can breeze into one of these new flagship stores, get treated, and even more »

  • This High-Flyer Is Still Too Cheap!

    By Brian Nichols - April 13, 2013 | Tickers: CVS, RAD, WAG

    Rite Aid (NYSE: RAD) rallied 15% in Thursday’s early session after posting an incredible Q4 earnings report. For the last four months I have been saying to buy this stock, and now that it has surpassed $2.00 and has provided full-year guidance, I say the stock still has lots of room ahead to rally higher.

    A look at the quarter

    Rite Aid’s quarter was simply amazing. The more »

  • Is Rite Aid on the Right Track?

    By Leo Sun - April 12, 2013 | Tickers: ESRX, RAD, WAG

    Shares of drugstore chain Rite Aid (NYSE: RAD) recently surged, after the third-largest drugstore chain in the United States reported a surprising return to profitability. The Camp Hill, Penn.-based company, which operates 4,600 drugstores across the United States, has underperformed its two larger peers, Walgreen (NYSE: WAG) and CVS Caremark, by a wide margin over the past five years.

    In this article, let’s examine the fundamentals at more »

  • The Key Earnings for the Week (April 8)

    By Lee Samaha - April 8, 2013 | Tickers: AA, FAST, MSM, PIR, RAD

    Is it just me or does it seem that earnings season should no longer be called a season, but rather an ongoing activity? Alcoa’s (NYSE: AA) results usually mark the beginning of the season, and as they come up next week, I guess it’s time to declare a new season open.

    It’s been a good quarter for equities, but some recent weakness in the ISM data is more »

  • Rite Aid Disappoints Again with March Numbers

    By Robert Lund - April 6, 2013 | Tickers: ABC, CVS, RAD, WAG

    Rite Aid Corporation (RAD) monthly sales declined by 2.0% and total drugstore sales declined by an additional 2.5% respectively on year-over-year according to a release by the company yesterday.

    Though March benefited from the Easter holiday this year, same store sales fell 2.0% versus the prior year's period. Total front-end sales did reflect the addition of the Holiday as sales rose 3.8% Y/Y with more »

  • The Key Earnings For The Week (April 8)

    By Lee Samaha - April 3, 2013 | Tickers: AA, FAST, MSM, PIR, RAD

    Is it just me or does it seems that earnings season should no longer be called a season but rather an ongoing activity? Alcoa’s (NYSE: AA) results usually mark the beginning of the season and, as they come up next week, I guess it’s time to declare a new season open.

    It’s been a good quarter for equities but some recent weakness in the ISM data is more »

  • Page 1 of 5